Who Paid My Doc
Hemgenix
Biological Hematology
NDC 0053-0100-10
General payments
$1,928,862
Research payments
$1,294,380
Through program year 2025, $1,928,862 in general payments and $1,294,380 in research payments were reported against Hemgenix (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $555,333 | 709 |
| 2025 | Research | $859,566 | 250 |
| 2024 | General | $674,558 | 761 |
| 2024 | Research | $434,814 | 119 |
| 2023 | General | $698,972 | 788 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,258 general · 369 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.